Aehr Test Systems (AEHR) Stock Surges 15% on Record $41M AI Chip Deal

TLDR

• Aehr Test Systems stock rose 15.41% Thursday after announcing a record $41 million production order from a hyperscale customer.
• The order is for package-level burn-in of custom AI processor ASICs using Aehr’s Sonoma high-power systems.
• Deliveries begin in fiscal year 2027, starting June 27, 2026.
• A company director sold $1.21 million in stock on April 16, the day before the announcement.
• Wall Street holds a Strong Buy consensus with an average price target of $62.

Aehr Test Systems landed the biggest order in its history Thursday, and Wall Street noticed. The company announced a $41 million production deal from its lead hyperscale customer for package-level burn-in of custom AI processor ASICs. AEHR stock surged 15.41% on the news.

Aehr Test Systems, AEHR

The order covers a large number of Aehr’s Sonoma high-power package-level test and burn-in systems. It also includes turnkey burn-in modules and device-specific sockets that configure the systems to specific AI processors.

This is a follow-on order, meaning the hyperscale customer — whose identity has not been disclosed — has worked with Aehr before. The deal builds on an already growing relationship.

Deliveries are set to begin in Aehr’s fiscal year 2027, which kicks off on June 27, 2026. That gives the company a clear runway of near-term revenue to look forward to.

CEO Gayn Erickson made clear this is not the end of the road. He noted the customer is also developing a next-generation, higher-power AI accelerator ASIC expected to move into production later this year.

Aehr has already received an initial order from that same customer for multiple Sonoma systems to support production of the newer device. That means this $41 million deal could be just the start of a larger wave.

Strong Momentum Heading Into the Announcement

Thursday’s move extends what has been a remarkable run for AEHR. The stock is up 246.95% year-to-date and has gained 805.07% over the past 12 months.

Over 1.75 million AEHR shares changed hands on the day, closing in on the three-month average daily volume of roughly 2.77 million.

The record order also comes on the heels of strong Q3 2026 results. Revenue came in at $10.3 million, slightly below the $10.8 million forecast, but the company posted record quarterly bookings of $37.2 million. That helped push its backlog past $50 million.

On earnings per share, Aehr beat expectations — reporting -$0.05 against the forecasted -$0.07.

Analyst and Insider Activity

Analysts have been raising their targets. Freedom Broker lifted its price target to $61 from $38 while maintaining a Hold rating. Lake Street raised its target to $56 from $50, citing strong booking momentum, and kept its Buy rating.

The overall Wall Street consensus is Strong Buy, with three Buy ratings in the past three months. The average price target sits at $62, implying roughly 26.67% upside from current levels.

On the insider side, Director Rhea J. Posedel sold 15,000 shares on April 16 at $80.72 per share, totaling $1.21 million. Following the sale, Posedel directly holds 71,163 shares, with an additional 411,979 shares held indirectly through a trust.

The post Aehr Test Systems (AEHR) Stock Surges 15% on Record $41M AI Chip Deal appeared first on CoinCentral.